Acrostak

Acrostak is a Swiss-based medical technology company that specializes in the design, development, and manufacturing of innovative interventional cardiology and vascular surgery devices. Founded in 2001, the company has established a strong reputation for its high-precision balloon catheters, particularly the 'Grip' line, which is engineered to treat complex and resistant vascular stenoses. Their product portfolio includes a wide range of Percutaneous Transluminal Coronary Angioplasty (PTCA) and Percutaneous Transluminal Angioplasty (PTA) catheters, as well as specialized stent delivery systems. Acrostak serves a global market, providing interventionalists with tools designed to improve procedural success in challenging anatomical environments. The company maintains rigorous quality standards, operating out of its headquarters in Steinen, Switzerland.